FF GENE BIOTECH
FF Gene Biotech was founded to bring Fulgent Genetics’ Next Generation Sequencing (NGS) capabilities to the Chinese genetic testing market.
Similar Organizations
Palo Santo Fund
Palo Santo Fund is an investment fund that invests in psychedelic and healthcare industry.
More informations about "FF Gene Biotech"
Fulgent Genetics Announces Incremental Strategic Investment in …
May 10, 2021 FF Gene Biotech was founded in 2017 to bring Fulgent Genetics’ Next Generation Sequencing (NGS) capabilities to the Chinese genetic testing market. ... including its sales …See details»
News Release - Fulgent Genetics
May 10, 2021 FF Gene Biotech was founded in 2017 to bring Fulgent Genetics’ Next Generation Sequencing (NGS) capabilities to the Chinese genetic testing market. ... including its sales …See details»
FF Gene Biotech - Products, Competitors, Financials, Employees ...
FF Gene Biotech formed in 2017 through a Joint Venture between Fulgent Genetics, Xilong Scientific, and Fuzhou Jinqiang Investment Partnership (FJIP). The company was founded to …See details»
Fulgent Genetics Makes $19M Investment in Chinese JV, Takes
May 10, 2021 Following its latest investment in FF Gene Biotech, Fulgent said it intends to increase testing capacity at the joint venture's Fujian-based facility and expand its sales …See details»
FF Gene Biotech - Crunchbase
FF Gene Biotech was founded to bring Fulgent Genetics’ Next Generation Sequencing (NGS) capabilities to the Chinese genetic testing market. Search Crunchbase. Start Free Trial . …See details»
Fulgent Therapeutics acquires FF Gene Biotech - Crunchbase
May 10, 2021 FF Gene Biotech FF Gene Biotech was founded to bring Fulgent Genetics’ Next Generation Sequencing (NGS) capabilities to the Chinese genetic testing market. Acquiring …See details»
FF Gene Biotech - PitchBook
When was FF Gene Biotech founded? FF Gene Biotech was founded in 2017. Where is FF Gene Biotech headquartered? FF Gene Biotech is headquartered in Fuzhou, China. What industry is …See details»
Fulgent Genetics, Inc. Announces Incremental Strategic Investment …
May 10, 2021 Fulgent Genetics, Inc. announced that the Company has made an incremental strategic investment in FF Gene Biotech, the Chinese entity formed in 2017 through a Joint …See details»
Fulgent Genetics Announces ~$19M Investment In Chinese Joint
May 10, 2021 Fulgent has made a cash investment of approximately $19.0 million in the Chinese entity, which gives Fulgent a majority stake and controlling ownership of FF Gene …See details»
Fulgent Genetics Announces Incremental Strategic Investment in
May 10, 2021 Fulgent Genetics, Inc., a technology company providing comprehensive testing solutions through its scalable technology platform, today announced that the Company has …See details»
Fulgent Genetics Reports Third Quarter Financial Results | Fulgent …
Sep 30, 2021 Our core business has been seeing strong momentum with the addition of CSI and integration of FF Gene Biotech, and we are continuing to make investments to drive our …See details»
Fulgent Genetics Reports Fourth Quarter and Full Year 2021 …
Dec 31, 2021 TEMPLE CITY, Calif.--(BUSINESS WIRE)--Feb. 23, 2022-- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics,” “Fulgent,” or the “Company”), a technology-based …See details»
Fulgent Genetics Announces Opening of New State-of-the-Art …
May 3, 2022 Fulgent Genetics is a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health.See details»
Fulgent Genetics Announces Incremental Strategic Investment
May 10, 2021 Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “Company”), a technology company providing comprehensive testing solutions through its scalable …See details»
FF Gene Biotech - Updates, News, Events, Signals & Triggers
May 10, 2021 FF Gene Biotech was founded to bring Fulgent Genetics’ Next Generation Sequencing (NGS) capabilities to the Chinese genetic testing market. Search Crunchbase. …See details»
Fulgent Genetics Reports Second Quarter Financial Results
Aug 9, 2021 Fulgent has purchased an incremental stake in the entity for approximately $19.0 million, giving Fulgent primary economic and operational ownership of FF Gene Biotech. FF …See details»
Jim Wilson's genetic medicines CRO names new CEO
2 days ago Franklin Biolabs, the genetic medicines contract research organization that gene therapy expert James Wilson, M.D., Ph.D., spun out of the University of Pennsylvania earlier …See details»
Fulgent Genetics Reports Fourth Quarter and Full Year 2021 …
Feb 23, 2022 FULGENT GENETICS, INC. Non-GAAP Income Reconciliation. Three and Twelve Months Ended December 31, 2021 and 2020 (in thousands, except per share data)See details»
Fulgent Genetics Announces Incremental Strategic Investment in
May 10, 2021 Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent Genetics" or the "Company"), a technology company providing comprehensive testing solutions through its scalable …See details»
VIVEbiotech Secures Growth Investment from Ampersand Capital …
2 days ago VIVEbiotech, a leading lentiviral vector Contract Development and Manufacturing Organization (CDMO), today announced a growth equity investment from Ampersand Capital …See details»